Literature DB >> 16621882

Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial.

P A Poole-Wilson1, S J Pocock, K A A Fox, R A Henderson, D J Wheatley, D A Chamberlain, T R D Shaw, T C Clayton.   

Abstract

OBJECTIVE: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time.
METHODS: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n = 895) or to a symptom-guided conservative strategy (n = 915).
RESULTS: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5-12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment-time interaction p = 0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram.
CONCLUSION: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621882      PMCID: PMC1861054          DOI: 10.1136/hrt.2005.060541

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  21 in total

1.  ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions.

Authors:  S C Smith; J T Dove; A K Jacobs; J W Kennedy; D Kereiakes; M J Kern; R E Kuntz; J J Popma; H V Schaff; D O Williams; R J Gibbons; J P Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

2.  5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

Authors:  K A A Fox; P Poole-Wilson; T C Clayton; R A Henderson; T R D Shaw; D J Wheatley; R Knight; S J Pocock
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry.

Authors:  Jason W Ryan; Eric D Peterson; Anita Y Chen; Matthew T Roe; E Magnus Ohman; Christopher P Cannon; Peter B Berger; Jorge F Saucedo; Elizabeth R DeLong; Sharon-Lise Normand; Charles V Pollack; David J Cohen
Journal:  Circulation       Date:  2005-11-07       Impact factor: 29.690

5.  Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.

Authors:  Shamir R Mehta; Christopher P Cannon; Keith A A Fox; Lars Wallentin; William E Boden; Rudolf Spacek; Petr Widimsky; Peter A McCullough; David Hunt; Eugene Braunwald; Salim Yusuf
Journal:  JAMA       Date:  2005-06-15       Impact factor: 56.272

6.  Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study.

Authors:  Frans Van de Werf; Joel M Gore; Alvaro Avezum; Dietrich C Gulba; Shaun G Goodman; Andrzej Budaj; David Brieger; Kami White; Keith A A Fox; Kim A Eagle; Brian M Kennelly
Journal:  BMJ       Date:  2005-01-21

7.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

8.  Early invasive versus selectively invasive management for acute coronary syndromes.

Authors:  Robbert J de Winter; Fons Windhausen; Jan Hein Cornel; Peter H J M Dunselman; Charles L Janus; Peter E F Bendermacher; H Rolf Michels; Gerard T Sanders; Jan G P Tijssen; Freek W A Verheugt
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

9.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

Authors: 
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

10.  Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators.

Authors:  S Yusuf; M Flather; J Pogue; D Hunt; J Varigos; L Piegas; A Avezum; J Anderson; M Keltai; A Budaj; K Fox; L Ceremuzynski
Journal:  Lancet       Date:  1998-08-15       Impact factor: 79.321

View more
  3 in total

Review 1.  Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes.

Authors:  Peter R Sinnaeve
Journal:  J Cardiovasc Transl Res       Date:  2011-11-01       Impact factor: 4.132

2.  Impact of myocardial revascularization on long-term outcomes in a nationwide cohort of first acute myocardial infarction survivors.

Authors:  Leonardo De Luca; Paola D'Errigo; Stefano Rosato; Gian Francesco Mureddu; Gabriella Badoni; Fulvia Seccareccia; Giovanni Baglio
Journal:  Eur Heart J Suppl       Date:  2022-05-18       Impact factor: 1.624

3.  Non-ST elevation myocardial infarction (NSTEMI) in three hospital settings in South Africa: does geography influence management and outcome? A retrospective cohort study.

Authors:  Jane Moses; Anton F Doubell; Philip G Herbst; Karl J C Klusmann; Hellmuth S V H Weich
Journal:  Cardiovasc J Afr       Date:  2013-05       Impact factor: 1.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.